The Future of Drug Development with Lonza’s AI-Powered Tools

DATE
07 October 2025
TIME
08:00 PDT, 11:00 EDT, 16:00 BST, 17:00 CEST
Duration: 60 Minutes

Overview

The webinar will show how it’s possible to gain a critical advantage in early-phase development by harnessing the power of Artificial Intelligence (AI). It will showcase how predictive AI is used to overcome traditional synthesis challenges, identifying optimal chemical routes that can significantly cut raw material costs and shorten timelines. A case study will highlight the real-world impact of this data-driven approach.

It will also describe how the complex task of solid-form screening can be enhanced by using a powerful AI platform. Machine learning models can even accurately predict and identify the most stable cocrystal forms. Overall, the webinar will provide a clear roadmap for using these AI tools to de-risk programs and accelerate the path to the clinic.

Key Learning Objectives:
  • Discover how AI can identify more efficient synthesis pathways
  • Learn how machine learning models can predict optimal crystal forms
  • Explore the real-world impact of these tools through a detailed case study
Who Should Attend:
  • Scientific and Technical Leaders
  • Program and Portfolio Managers
  • Business Development Managers

Speakers

Aaron Johnson, PhD
Manager, Cheminformatics & Data Science,
Lonza Advanced Synthesis
Simon Wagschal, PhD
Associate Director,
Lonza Advanced Synthesis

Registration

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society and its sponsor via email. You understand that you can withdraw your consent at any time. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.
Brought to you by:
Lonza logo

© 2025 American Chemical Society, 1155 16th St NW, Washington, DC 20036, USA. View our Privacy Policy